Nanomedicine, an emerging discipline at the intersection of nanotechnology and healthcare, is reshaping the way diseases are diagnosed, treated, and prevented. This paper presents a thorough examination of the field’s progression—from its theoretical inception in Richard Feynman’s foundational ideas to the development of practical nanotherapeutics such as liposomes, polymeric and metallic nanoparticles, and dendrimers. It explores how nanoscale systems enable targeted drug delivery, improved imaging, and controlled therapeutic release through mechanisms like the enhanced permeability and retention (EPR) effect, active molecular targeting, and stimuli-sensitive responses. Key medical applications in oncology, infectious disease management, regenerative therapies, and diagnostics are discussed. The review also addresses critical concerns regarding safety, regulation, affordability, and ethics. Additionally, it highlights ongoing innovations in personalized medicine, AI-assisted nanoparticle design, and multifunctional therapeutic platforms. As research advances, nanomedicine holds the promise to become a central pillar of individualized and highly efficient medical care.
Sanjay K. Tupe (Wed,) studied this question.